Skip to main content
. Author manuscript; available in PMC: 2013 May 16.
Published in final edited form as: Acta Pharm Sin B. 2012 Apr 1;2(2):213–219. doi: 10.1016/j.apsb.2012.02.008

Figure 3.

Figure 3

Plasma concentration-versus-time curves of prodrugs and parent compound. (A) 3 with PEG400, i.v. administration at 2 mg/kg, and (B) prodrugs and 3 with PEG400, i.g. administration at 20 mg/kg. Results are averages of three independent assays.